Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Completed · Phase 3

Conditions studied: Cholestasis

In brief

Use of a fish oil emulsion to decrease liver disease due to long term intravenous nutrition.

Key facts

Study ID

NCT01194063

Run by

Kapiolani Medical Center For Women & Children

People needed

36

Starts

2010-10-20

Expected to finish

2019-01-15

Last updated by the study team

2026-04-03

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• direct bilirubin > 2 mg/dl x2 consecutive
• parenteral nutrition dependent, expected to continue for at least another 30 days from the first day
• patient must have utilized standard therapies to prevent the progression of liver disease

You may not qualify if…

• other primary cause of liver disease not parenteral nutrition-associated
• weight <3 kg
• infant or child enrolled in other clinical trial involving an investigational agent

Where it is running

• Kapiolani Medical Center for Women and Children — Honolulu, Hawaii, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.